Statin-triggered immune-mediated necrotizing myopathy

被引:3
作者
Patel, Samir [1 ]
Rohatgi, Anshu [1 ]
Gupta, Pooja [1 ]
机构
[1] Sir Ganga Ram Hosp, Dept Neurol, New Delhi, India
关键词
D O I
10.4103/0028-3886.181571
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
引用
收藏
页码:562 / +
页数:3
相关论文
共 7 条
[1]   Statin induced necrotizing autoimmune myopathy [J].
Babu, Suma ;
Li, Yuebing .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 351 (1-2) :13-17
[2]   IMMUNE-MEDIATED NECROTIZING MYOPATHY ASSOCIATED WITH STATINS [J].
Grable-Esposito, Phyllis ;
Katzberg, Hans D. ;
Greenberg, Steven A. ;
Srinivasan, Jayashri ;
Katz, Jonathan ;
Amato, Anthony A. .
MUSCLE & NERVE, 2010, 41 (02) :185-190
[3]   Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs [J].
Graham, DJ ;
Staffa, JA ;
Shatin, D ;
Andrade, SE ;
Schech, SD ;
La Grenade, L ;
Gurwitz, JH ;
Chan, KA ;
Goodman, MJ ;
Platt, R .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (21) :2585-2590
[4]   Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effects [J].
Mammen, Andrew L. ;
Pak, Katherine ;
Williams, Emma K. ;
Brisson, Diane ;
Coresh, Joe ;
Selvin, Elizabeth ;
Gaudet, Daniel .
ARTHRITIS CARE & RESEARCH, 2012, 64 (02) :269-272
[5]   Autoantibodies Against 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase in Patients With Statin-Associated Autoimmune Myopathy [J].
Mammen, Andrew L. ;
Chung, Tae ;
Christopher-Stine, Lisa ;
Rosen, Paul ;
Rosen, Antony ;
Doering, Kimberly R. ;
Casciola-Rosen, Livia A. .
ARTHRITIS AND RHEUMATISM, 2011, 63 (03) :713-721
[6]   Progressive myopathy with up-regulation of MHC-I associated with statin therapy [J].
Needham, Merrilee ;
Fabian, Victoria ;
Knezevic, Wally ;
Panegyres, Peter ;
Zilko, Paul ;
Mastaglia, Frank L. .
NEUROMUSCULAR DISORDERS, 2007, 17 (02) :194-200
[7]   Muscle symptoms associated with statins:: A series of twenty patients [J].
Soininen, K ;
Niemi, M ;
Kilkki, E ;
Strandberg, T ;
Kivistö, KT .
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2006, 98 (01) :51-54